Borrebaeck, Carl A.K.

Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer

Mellby, L. D., Nyberg, A. P., Johansen, J. S., Wingren, C., Nordestgaard, B. G., Bojesen, S. E., Mitchell, B. L., Sheppard, B. C., Sears, R. C., & Borrebaeck, C. A. K. (2018) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 159

Animal‐free alternatives and the antibody iceberg

Gray, A., Bradbury, A. R. M., Knappik, A., Plückthun, A., Borrebaeck, C. A. K., & Dübel, S. (2020) · Nature Biotechnology

Monoclonal and Polyclonal Antibodies ResearchAnimal testing and alternatives

Cited by 111

Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature

Ghatnekar, O., Andersson, R., Svensson, M., Persson, U., Ringdahl, U., Zeilon, P., & Borrebaeck, C. A. K. (2013) · International Journal of Cancer

Pancreatic and Hepatic Oncology ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 85

Animal‐friendly affinity reagents: replacing the needless in the haystack

Gray, A. C., Sidhu, S. S., Chandrasekera, P. C., Hendriksen, C. F. M., & Borrebaeck, C. A. K. (2016) · Trends in Biotechnology

Animal testing and alternativesMonoclonal and Polyclonal Antibodies Research

Cited by 55

An artificial intelligence-powered, patient-centric digital tool for self-management of chronic pain: a prospective, multicenter clinical trial

Barreveld, A. M., Rosén Klement, M. L., Cheung, S., Axelsson, U., Basem, J. I., Reddy, A. S., Borrebaeck, C. A. K., & Mehta, N. (2023) · Pain Medicine

Musculoskeletal pain and rehabilitationMobile Health and mHealth Applications

Cited by 22